Ustekinumab again linked to cardiovascular events

WAIKOLOA, HAWAII – The anti-interleukin-12/23 biologic agents ustekinumab and briakinumab were associated with a statistically significant 4.23-fold increased risk of major adverse cardiac events in...

Field of Interest: Dermatology
Type: News Item

VIDEO: Bright future ahead for U.S. sunscreen market

WAIKOLOA, HAWAII – A new wave of better sunscreens may soon wash into the U.S. marketplace, predicted Dr. Susan Swetter of Stanford (Calif.) University. She spoke with us at the Hawaii Dermatology...

Field of Interest: Dermatology
Type: News Item

Novel topical rosacea drug sails through phase III

WAIKOLOA, HAWAII – Ivermectin 1% cream for the treatment of papulopustular rosacea convincingly hit all of its primary efficacy and safety endpoints in two pivotal phase III clinical trials. The...

Field of Interest: Dermatology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.